Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sickle Cell Disease Stem Cell Mobilization and Apheresis Using Motixafortide

NCT06442761 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.

NCT NCT06442761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06442761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sickle Cell Disease Stem Cell Mobilization and Apheresis Using Motixafortide
Lead sponsor
St. Jude Children's Research Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
November 14, 2024
Completion date
July 31, 2028
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease